Biopolym. Cell. 1993; 9(4):63-104.
Gene-Engineering Biotechnology
Gene therapy of mass pathologies
1Kordyum V. A., 1Frolkis V. V., 1Lukash L. L., 1Shulzhenko V. N., 1Shpilevaya S. P., 1Kostetsky I. E., 1Titok T. G., 1Varsanova I. S., 1Likhacheva L. I., 1Irodov D. M.
  1. Institute of Molecular Biology and Genetics, NAS of Ukraine
    150, Akademika Zabolotnoho Str., Kyiv, Ukraine, 03680

Abstract

The whole complex of investigations is described that allows to run the way from the idea to experimental realization of a fundamental possibility of gene therapy and its application to mass pathologies on the sample of insulin-dependent diabetes and atherosclerosis. The search and analysis were performed of such regulatory elements that would permit an expression irrespective of the state of a general cell regulation. Expression of the implanted gene material is shown on cells of different tissues and different organisms and also in vivo (both the model gene of β-galactosidase Escherichia coli and insulin- and apolipoprotein high density Al-coding genes related to above stated pathologies). It is concluded that the results obtained in the culture outside the organisms shouldn't be extrapolated on the animals, i. e. on the organism's level. The expression of recombinant molecules is shown to be ambiguous and depend on gene's surroundings and the type of recipient cells. Both in the culture and in the organism the individual cell heterogeneity is observed in the quantitative characteristics of the expression of gene implanted from outside. Besides, an individual organism and age heterogeneity with regard to the expression of the exogenous gene is reported. The conclusion is made about the necessity to individualize gene therapy of mass pathologies.

References

[1] Kordium VA. Objectives and problems of gene therapy. Biopolym Cell. 1989; 5(2):5-16.
[2] Kordium VA. Possibilities of gene therapy for treatment and prevention of mass pathologies. Biopolym Cell. 1990; 6(1):12-31.
[3] Miller JH. Experiments in molecular genetics. Cold Spring Harbor Laboratory, 1972, 466 p.
[4] DNA cloning: a practical approach. Ed. DM Glover. Oxford, IRL Press, 1985; Vol. 1 and 2: 435 p
[5] Storms RK, McNeil JB, Khandekar PS, An G, Parker J, Friesen JD. Chimeric plasmids for cloning of deoxyribonucleic acid sequences in Saccharomyces cerevisiae. J Bacteriol. 1979;140(1):73-82.
[6] An G, Hidaka K, Siminovitch L. Expression of bacterial beta-galactosidase in animal cells. Mol Cell Biol. 1982;2(12):1628-32.
[7] Maniatis T, Fritsch EF, Sambrook J. Molecular cloning: a laboratory manual. New York: Cold Spring Harbor Lab, 1982; 545 p.
[8] Miroshnichenko GP, Dyachenko AF. Modern methods of the DNA isolation from the higher plants. Usp Sovrem Biol. 1991; 1: 49-60.
[9] Maxam AM, Gilbert W. Sequencing end-labeled DNA with base-specific chemical cleavages. Methods Enzymol. 1980;65(1):499-560.
[10] Bilich KM, Irodov DM, Kordium VA. Some ultrastructural aspects of direct injection of liposomes with inclosed plasmid DNA into mice liver. Biopolym Cell. 1990;6(1):73-82.
[11] Zilber A. Immunological analysis. Moscow, Medicine, 1968; 185 p.
[12] Ngo TT, Lenhoff HM. Enzyme-mediated immunoassay. Plenum, New York, 1985; 480 p.
[13] Graham FL, van der Eb AJ. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology. 1973;52(2):456-67.
[14] Gaal ?, Medgyesi G A, Vereczkey L. Electrophoresis in the separation of biological macromolecules. John Wiley & Sons, Chichester, UK and Akademiai Kiado, Budapest. 1980; 422 p.
[15] Abel LL, Levy BB, Brodie BB, Kendall FE. A simplified method for the estimation of total cholesterol in serum and demonstration of its specificity. J Biol Chem. 1952;195(1):357-66.
[16] Kiriakov A, Tinterova Z. Determination of cholesterol and triglyceride content in blood serum lipoproteins isolated by the double precipitation method. Lab Delo. 1979;(7):398-402.
[17] Kiryakov A, Tinteropa Z, Stoyanova S. Electrophoresis of serum lipoproteins on the top of the agarose gel. Sovremennaya Meditsina. 1977; 28(4):29-35.
[18] Klimov AN, Usatenko MS, Denisenko AD, Kozhevnikova KA, Ole?nik IA. Isolation of apolipoproteins A-I, A-II and E and their estimation by rocket immunoelectrophoresis in blood plasma of dis-alpha-lipoproteinemic patients. Biokhimiia. 1981;46(4):590-602.
[19] Markwell MA, Haas SM, Bieber LL, Tolbert NE. A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Anal Biochem. 1978;87(1):206-10.
[20] Kates M. Techniques of lipidology: isolation, analysis and identification of lipids. North-Holland Publishing Company, 1975; 269 p.
[21] Svanborg A, Svennerholm L, Myr?n I, Soom?gi MR, Claesson B, Rohman S. Plasma total lipid, cholesterol, triglycerides, phospholipids and free fatty acids in a healthy scandinavian population. Acta Med Scand. 1961;169(1):43–9.
[22] Swaney JB, Kuehl KS. Separation of apolipoproteins by an acrylamide-gradient sodium dodecyl sulfate gel electrophoresis system. Biochim Biophys Acta. 1976;446(2):561-5.
[23] Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970;227(5259):680-5.
[24] Karuzina II, Archakov AI. Isolation of liver microsomal fractions and characterization of its oxidation systems. Modern methods in biochemistry. M.: Medicine, 1977: 49-62.
[25] Omura T, Sato R. The carbon monoxide-binding pigment of liver microsomes. II. Solubilization, purification, and properties. J Biol Chem. 1964;239:2379-85.
[26] Ernst B, Tasman D. Immunology. Immunological Methods. Moscow, Mir, 1979; 373-413.
[27] Rhodes JM, Blom J. Cytochemical localization of beta-galactosidase in resident and inflammatory peritoneal macrophages from C57BL mice. Histochemistry. 1986;86(2):159-64.
[28] Kirillova VS, Irodov DM, Usenko EV et al. Study of the lacZ gene expression in the culture of the E. coli L-cells. Novye napravleniya biotekhnologii: Tez. dokl. Vsesoyuz. konf. 1988: 8-10.
[29] Kordium VA, Kostetsky IE, Shpilevaya SP. et al. Studies of recombinant expression in various animals tissue cells. II Symp. USSR-USA. Moscow, 1989.
[30] Varzanova IS, Neborachko LN, Shpilevaya SP, Kosletsky IE, Stolyar TV, Sukhorada EM, Lukash LL, Kordium VA. Comparative studies in expression of model bacterial ?-galactosidase gene in culture of murine fibroblasts and during direct injection into the animal liver. Biopolym Cell. 1990; 6(1):67-73.
[31] Shpilevaya SP, Likhacheva LI, Varzanova IS et al. Expression of the lacZ gene of E.coli in the culture of mammalian cells. Human Gemone: I All-Union. conf. 1990: 143-4.
[32] Kostetskiy IE. Shpilevaya SP, Likhacheva LI et al. Expression of the lacZ gene of E.coli in the mammalian cells.. Human Gemone: I All-Union. conf. 1990: 199-120
[33] Kostetsky IE, Shpilevaya SP, Likhacheva LI, Zharova LC, Irodov DM, Kirillova VS, Kordium VA. Expression of Escherichia coli ?-Galactosidase in murine hepatocytes. Biopolym Cell. 1989; 5(2):51-8.
[34] Shpilevaya SP, Kostetsky IE, Likhacheva LI, Zharova LG, Irodov DM, Usenko EV, Stolyar TV, Kordium VA. Comparative studies in efficiency of expression of bacterial ?-galactosidase in vivo by the immunofluorescence method. Biopolym Cell. 1990; 6(1):63-6.
[35] Mazovetskiy AG, Velikov VP. Diabetes. Moscow: Meditsina, 1987, 288 p.
[36] Shoelson S, Fickova M, Haneda M, Nahum A, Musso G, Kaiser ET, Rubenstein AH, Tager H. Identification of a mutant human insulin predicted to contain a serine-for-phenylalanine substitution. Proc Natl Acad Sci U S A. 1983;80(24):7390-4.
[37] Birch NP, Christie DL, Renwick AG. Proinsulin-like material in mouse foetal brain cell cultures. FEBS Lett. 1984;168(2):299-302.
[38] Walker MD, Edlund T, Boulet AM, Rutter WJ. Cell-specific expression controlled by the 5'-flanking region of insulin and chymotrypsin genes. Nature. 1983 Dec 8-14;306(5943):557-61.
[39] Niven MJ, Hitman GA. The molecular genetics of diabetes mellitus. Biosci Rep. 1986;6(6):501-12.
[40] Laub O, Rall L, Bell GI, Rutter WJ. Expression of the human insulin gene in an alternate mammalian cell and in cell extracts. J Biol Chem. 1983;258(10):6037-42.
[41] Gluzman Y. SV40-transformed simian cells support the replication of early SV40 mutants. Cell. 1981;23(1):175-82.
[42] Neborachko LN, Lukash LL, Troyanovsky BM, Varzanova IS, Buzhievskaya T. I., Kordium VA. Studies in possibility of expression of exogenic human insulin gene in cultured mammalian fibroblasts. Biopolym Cell. 1989; 5(2):58-61.
[43] Lukash LL, Neborachko LN, Podolskaya SV, Varzanova IS, Titok TG, Buzhievskaya TI, Kordyum VA. Expression of exogenic human insulin gene in subcultures and clones of cultivated fibroblasts. Doklady Akad Nauk Ukr SSR. Ser B. 1989;(8):71-4.
[44] Lukash LL, Neborachko LN, Troyanovskiy BM. Expression of exogenous gene in cultured human insulin mammalian fibroblasts. Gene and Cell Engineering in solving the fundamental problems of biotechnology: Materials Proc. conf. (Tartu K??riku, September 20-22, 1988). Tartu state univ, 1989. vol 1. 200 p.
[45] Cline MJ, Stang H, Mercola K, Morse L, Ruprecht R, Brown J, Salser W. Gene transfer in intact animals. Nature. 1980;284(5755):422-5.
[46] van Wyke KL, Hinshaw VS, Bean WJ Jr, Webster RG. Antigenic variation of influenza A virus nucleoprotein detected with monoclonal antibodies. J Virol. 1980;35(1):24-30.
[47] Lukash LL, Neborachko LN, Sukhorada EM, Usenko EV, Varsanova IS, Podolskaya SV, Buzhievskaya TI, Kordium VA. Human insulin gene expression in cultured mammalian cells. Biopolym Cell. 1990; 6(1):82-87.
[48] Titok TG, Kostetsky IE, Chaikovskaya TL, Kochubej TP, Zharova LG, Kirilenko SD, Melnik IM, Silvanskaya EM, Buzhievskaya TI, Kordium VA. Transfer of human preproinsulin gene into streptozotocin diabetic rats. Biopolym Cell. 1990; 6(2):76-80.
[49] Titok TG, Kostetsky IE, Tchaikovskaya TL, Varzanova IS, Kochubey TP, Lukash LL, Kordium VA. Transplantation of human preproinsulin gene into the insuline dependent diabetic and normal rats. Biopolym Cell. 1993; 9(1):39-44.
[50] Decker K. Biologically active products of stimulated liver macrophages (Kupffer cells). Eur J Biochem. 1990;192(2):245-61.
[51] Lyashenko VA, Drozhennikov VA, Molotkovskaya IM. Mechanisms of immune cells activation. Moscow, Medicine, 1988; 239 p.
[52] Cordle SR, Whelan J, Henderson E, Masuoka H, Weil PA, Stein R. Insulin gene expression in nonexpressing cells appears to be regulated by multiple distinct negative-acting control elements. Mol Cell Biol. 1991;11(5):2881-6.
[53] Cordell B, Diamond D, Smith S, P?nter J, Sch?ne HH, Goodman HM. Disproportionate expression of the two nonallelic rat insulin genes in a pancreatic tumor is due to translational control. Cell. 1982;31(3 Pt 2):531-42.
[54] Repin VS. Human Atherosclerosis: cellular and molecular mechanisms. Usp Sovrem Biol. 1990; 109(1):120-9.
[55] Shulhzenko VN, Novikova SN, Kostetsky IE, Bogatskaya LN, Frolhis VV, Kordium VA. Transfer of cloned human gene ApoA1 into adult and old rabbits. Biopolym Cell. 1990; 6(2):71-6.
[56] Shoulders CC, Baralle FE. Isolation of the human HDL apoprotein A1 gene. Nucleic Acids Res. 1982;10(16):4873–82.
[57] Shakhmuradov IA, Kolchanov NA, Solov'ev VV, Ratner VA. Enhancer-like structures in moderately repetitive sequences of eukaryotic genomes. Genetika. 1986;22(3):357-67.
[58] Shulzhenko VN, Lukash LL, Shulyak LN, Usenko EV, Kordyum VA. Cloning of human ApoA1 gene and its expression in murine fibroblasts. Biopolym Cell. 1989; 5(5):105-7.
[59] Shulzhenko VN, Kordyum VA. Cloning of the Zea maize genome DNA sequences capable of autonomous replication in Saccharomyces cerevisiae. Biopolym Cell. 1987; 3(5):270-4.
[60] Kordyum VA, Trukhanov VA, Toporova EK, Shulzhenko VN, Checheneva TN. Replication of recombinant DNA in tobacco protoplasts. Biopolym Cell. 1987; 3(3):145-8.
[61] Frol'kis VV, Kordium VA, Bogatskaia LN, Novikova SN, Shul'zhenko VN, Kostetski? IE, Potapenko RI, Sabko VE, Mozzhukhina TG, Paramonova GI, et al. The implantation of the human ApoAI gene into aged animals. Dokl Akad Nauk SSSR. 1991;316(5):1264-7.
[62] Frolkis VV, Kordium VA, Bogatskaya LN, Novikova SN, Shulzhenko VN, Kostetsky IE, Mozzhukhina TG, Potapenko RI, Sabko VE, Paramonova GI. Age peculiarities of human apoAl gene implantation effect on the development of dislipoproteidemias in the experimental animals. Biopolym Cell. 1991; 7(2):103-9.
[63] Frolkis VV, Kordjum VA, Bogatskaya LN, Novikova SN, Shulzhenko VN, Kostetsky IE, Mozzhukhina TG, Potapenko RI, Sabko VE, Paramonova GI, Shkapenko AL. Effect of transfer of human ApoA1 gene on development of dyslipoproteinemias in rats: Age peculiarities. Arch Gerontol Geriatr. 1991;13(3):225-35.
[64] Kordium VA. Gene trerapy is inevitable. But shall we have time? Kiev. 1991; 91 p.
[65] Saku K, Yamamoto K, Sakai T, Yanagida T, Hidaka K, Sasaki J, Arakawa K. Kinetics of HDL-apo A-I in the WHHL rabbit, an animal model of familial hypercholesterolemia. Atherosclerosis. 1989;79(2-3):225-30.
[66] Kordyum VA. The problem of survival: from transitory stay in extreme situation to constant inhabiting in extreme conditions. Biopolym Cell. 1992; 8(2):3-36.